Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

99.43 +4.24 (+4.45%)
Delayed Quote Updated: 11:56 AM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 Next >
News headline image
CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Progress Trial Demonstrates Edwards TAVR Is Superior to Clinical Surveillance for Moderate AS Patients With At-Risk Features
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Comments on TAVR National Coverage Decision
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
Edwards Comments on JenaValve Acquisition
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.